ストックスクリーナーアプリを入手
48.63
0.56%
0.27
アフターアワーズ：
48.63
前日終値:
$48.36
開ける：
$48.525
24時間の取引高:
369.38K
Relative Volume:
0.80
時価総額：
$1.54B
収益：
$566.77M
当期純損益:
$48.16M
株価収益率:
40.87
EPS:
1.19
ネットキャッシュフロー:
$274.29M
1週間 パフォーマンス:
+1.50%
1か月 パフォーマンス:
+2.70%
6か月 パフォーマンス:
+64.29%
1年 パフォーマンス:
+61.62%
1日の値動き範囲:
$47.85
$48.97
1週間の範囲:
$46.15
$49.16
52週間の値動き範囲:
$23.23
$49.16
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
名前
Collegium Pharmaceutical Inc
セクター
電話
781-713-3699
住所
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
COLL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
48.63 | 1.53B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-01-10 | アップグレード | Needham | Hold → Buy |
| 2024-07-30 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | アップグレード | Jefferies | Hold → Buy |
| 2024-05-10 | ダウングレード | Needham | Buy → Hold |
| 2024-05-10 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | ダウングレード | Jefferies | Buy → Hold |
| 2023-08-25 | 繰り返されました | Needham | Buy |
| 2023-05-02 | 再開されました | Jefferies | Buy |
| 2022-08-08 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-14 | 開始されました | BWS Financial | Sell |
| 2020-05-27 | 開始されました | Guggenheim | Neutral |
| 2020-02-19 | 再開されました | Jefferies | Buy |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-03 | 再開されました | H.C. Wainwright | Buy |
| 2019-04-12 | 再開されました | Janney | Buy |
| 2019-03-20 | 開始されました | SunTrust | Hold |
| 2019-01-16 | 繰り返されました | Needham | Buy |
| 2018-03-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-02-07 | 繰り返されました | Needham | Buy |
| 2017-12-05 | 繰り返されました | Needham | Buy |
| 2017-09-11 | 開始されました | H.C. Wainwright | Buy |
| 2017-05-11 | 繰り返されました | Needham | Buy |
| 2016-09-13 | 開始されました | Gabelli & Co | Buy |
| 2015-06-01 | 開始されました | Jefferies | Buy |
| 2015-06-01 | 開始されました | Needham | Buy |
| 2015-06-01 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Collegium Pharmaceutical Inc (COLL) 最新ニュース
Collegium Pharmaceutical Inc 354 Stock Analysis and ForecastMarket Volatility Update & Exceptional Return Growth - earlytimes.in
Collegium Pharmaceutical stock hits all-time high at 49.11 USD By Investing.com - Investing.com Canada
Collegium pharmaceutical EVP Dreyer sells $847k in stock - Investing.com India
Collegium pharmaceutical EVP Dreyer sells $847k in stock By Investing.com - Investing.com Australia
Collegium Pharmaceutical Insider Sold Shares Worth $847,855, According to a Recent SEC Filing - marketscreener.com
Does Zacks’ Value Spotlight on Collegium (COLL) Reframe Its Cash-Flow Story for Investors? - simplywall.st
Barclays Initiates Collegium Pharmaceutical at Overweight With $58 Price Target - marketscreener.com
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 12-Month HighWhat's Next? - MarketBeat
Collegium (NASDAQ:COLL) Nasdaq Biggest Companies Pharma Activity - Kalkine Media
Collegium Pharmaceutical (COLL): Revisiting Valuation After Fresh Coverage and Ongoing Earnings Outperformance - Yahoo Finance
Collegium Pharmaceutical (COLL): Assessing Valuation After Earnings Beats, Strong Zacks Rating and Value Investor Interest - simplywall.st
Can Collegium Pharmaceutical Inc. stock withstand economic slowdown2025 Sector Review & Safe Investment Capital Preservation Plans - Newser
Collegium Pharmaceutical, Inc. (COLL) Hits Fresh High: Is There Still Room to Run? - sharewise.com
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now? - sharewise.com
Can Collegium Pharmaceutical Inc. (354) stock hit consensus price targetsJuly 2025 News Drivers & Consistent Growth Stock Picks - Newser
What RSI levels show for Collegium Pharmaceutical Inc. (354) stockEarnings Trend Report & Weekly High Return Forecasts - Newser
How Collegium Pharmaceutical Inc. stock responds to policy changesWeekly Trade Recap & Real-Time Stock Movement Alerts - Newser
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 12-Month HighStill a Buy? - MarketBeat
Will Collegium Pharmaceutical Inc. (354) stock justify high valuationQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - Newser
Will Collegium Pharmaceutical Inc. (354) stock benefit from commodity supercycle2025 Investor Takeaways & Weekly Chart Analysis and Guides - Newser
Will Collegium Pharmaceutical Inc. (354) stock sustain uptrend momentum2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Collegium Pharmaceutical stock hits all-time high at 48.19 USD By Investing.com - Investing.com Australia
Collegium Pharmaceutical stock hits all-time high at 48.19 USD - Investing.com
Loomis Sayles & Co. L P Increases Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Will Collegium Pharmaceutical Inc. (354) stock hit analyst forecastsWeekly Stock Report & AI Enhanced Trade Execution Alerts - Newser
Can Collegium Pharmaceutical Inc. (354) stock withstand sector downturnsPortfolio Risk Report & AI Driven Price Forecasts - Newser
Why Collegium Pharmaceutical Inc. (354) stock is a strong analyst pickTrade Volume Report & Real-Time Volume Surge Alerts - Newser
Ballast Asset Management LP Makes New Investment in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Geode Capital Management LLC Increases Stock Holdings in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Collegium Pharmaceutical, Inc. (COLL) Stock Forecasts - Yahoo Finance
Collegium Pharmaceutical Reports Record Q3 2025 Results - MSN
Collegium Pharmaceutical (COLL): Exploring Valuation After Recent Share Price Surge - simplywall.st
Precision Trading with Collegium Pharmaceutical Inc. (COLL) Risk Zones - news.stocktradersdaily.com
Is Collegium Pharmaceutical Inc 354 a good long term investmentEarnings Per Share Trends & Low Risk Portfolio Growth - earlytimes.in
Why Investors Shouldn't Be Surprised By Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 26% Share Price Surge - 富途牛牛
Free cash flow per share of Collegium Pharmaceutical, Inc. – TRADEGATE:354 - TradingView
Collegium Pharmaceutical collaborates with Paris Hilton - MSN
Brandywine Global Investment Management LLC Increases Stake in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Why 2025 is a Dynamic and Transformative Year for Collegium - MSN
1 Small-Cap Stock with Exciting Potential and 2 We Avoid - The Globe and Mail
Has Analyst Spotlight on COLL Revealed a Turning Point in Its Competitive Advantage? - simplywall.st
Why Collegium Pharmaceutical Inc. stock is popular among millennialsPortfolio Gains Summary & Free Safe Entry Trade Signal Reports - newser.com
Is Collegium Pharmaceutical Inc. (354) stock a safe buy pre earningsQuarterly Risk Review & Safe Capital Growth Trade Ideas - newser.com
Collegium Pharmaceutical Inc (COLL) 財務データ
収益
当期純利益
現金流量
EPS
1.48%
0.09%
大文字化:
|
ボリューム (24 時間):